Pfenex Inc. (PFNX) financial statements (2022 and earlier)

Company profile

Business Address 10790 ROSELLE STREET
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments55,62456,22057,66481,501106,16245,722
Cash and cash equivalents55,62456,22057,66481,501106,16245,722
Restricted cash and investments200200200 3,959 
Receivables5,6002071,9387175081,584
Inventory, net of allowances, customer advances and progress billings    2423
Inventory    2423
Other current assets2,3081,8511,7051,8781,6941,753
Other undisclosed current assets285,17162,8222,6833,683
Total current assets:63,76063,64961,51386,918115,03052,765
Noncurrent Assets
Finance lease, right-of-use asset779
Operating lease, right-of-use asset3,124
Property, plant and equipment7,7447,6717,3975,2463,1792,310
Intangible assets, net (including goodwill)9,3109,82510,34810,87811,40911,940
Goodwill5,5775,5775,5775,5775,5775,577
Intangible assets, net (excluding goodwill)3,7334,2484,7715,3015,8326,363
Restricted cash and investments     3,955
Other noncurrent assets1701331338012153
Other undisclosed noncurrent assets    1,955 
Total noncurrent assets:21,12717,62917,87816,20416,66418,258
TOTAL ASSETS:84,88781,27879,391103,122131,69471,023
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,02411,81710,81810,6968,5595,179
Accounts payable6732,0051,9051,2848861,129
Accrued liabilities7,3519,8128,9139,4125,9972,633
Employee-related liabilities     1,417
Taxes payable    1,676 
Deferred revenue75
Debt951316228 3,8133,813
Deferred revenue and credits7,4216,5163,870201
Other liabilities616     
Other undisclosed current liabilities 5,317   (1,417)
Total current liabilities:9,66617,45018,46717,21216,2427,776
Noncurrent Liabilities
Long-term debt and lease obligation  419   
Capital lease obligations 419   
Liabilities, other than long-term debt261912,7425,76544,2713,373
Deferred revenue and credits2,7425,73944,225 
Deferred tax liabilities, net    3,281
Other liabilities26191 264692
Other undisclosed noncurrent liabilities2,8962,500    
Total noncurrent liabilities:2,9222,6913,1615,76544,2713,373
Total liabilities:12,58820,14121,62822,97760,51311,149
Stockholders' equity
Stockholders' equity attributable to parent72,29961,13757,76380,14571,18159,874
Common stock333224242421
Additional paid in capital270,008262,405219,446216,144212,661173,141
Accumulated deficit(197,742)(201,300)(161,707)(136,023)(141,504)(113,288)
Total stockholders' equity:72,29961,13757,76380,14571,18159,874
TOTAL LIABILITIES AND EQUITY:84,88781,27879,391103,122131,69471,023

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues50,32614,85728,78060,1949,58310,644
Cost of revenue(4,891)(5,022)(5,156)(5,313)(4,640)(7,233)
Gross profit:45,4359,83523,62454,8814,9433,411
Operating expenses(44,611)(49,686)(49,599)(49,758)(32,781)(13,128)
Operating income (loss):824(39,851)(25,975)5,123(27,838)(9,717)
Nonoperating income23525811914974 
Interest and debt expense     (77)
Income (loss) from continuing operations before income taxes:1,059(39,593)(25,856)5,272(27,764)(9,794)
Income tax expense (benefit)(1) 172209(452) 
Net income (loss) available to common stockholders, diluted:1,058(39,593)(25,684)5,481(28,216)(9,794)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):1,058(39,593)(25,684)5,481(28,216)(9,794)
Comprehensive income (loss), net of tax, attributable to parent:1,058(39,593)(25,684)5,481(28,216)(9,794)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: